share_log

兰卫医学(301060.SZ):公司对肺炎支原体及耐药基因检测具备足够的检测能力和技术储备

Lanwei Medicine (301060.SZ): The company has sufficient testing capabilities and technical reserves for mycoplasma pneumoniae and drug resistance genetic testing

Gelonghui Finance ·  Dec 12, 2023 02:37

On December 12, Gelonghui Medical (301060.SZ) stated on the investor interactive platform on December 12 that the company has sufficient testing capabilities and technical reserves for mycoplasma pneumoniae and drug resistance genetic testing to meet customer needs.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment